SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
SUTRO BIOPHARMA reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
SUTRO BIOPHARMA reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, four executives at SUTRO BIOPHARMA received on average a compensation package of $1.5M, a 2% decrease compared to previous year.
Average pay of disclosed executives at SUTRO BIOPHARMA
William J. Newell, Chief Executive Officer, received $2.2M in total, which decreased by 44% compared to 2019. 33% of Newell's compensation, or $708K, was in option awards. Newell also received $319K in non-equity incentive plan, $554K in salary, $555K in stock awards, as well as $21K in other compensation.
Linda Fitzpatrick, Chief People and Communications Officer, received a compensation package of $1.3M, which increased by 83% compared to previous year. 29% of the compensation package, or $382K, was in salary.
Trevor Hallam, Chief Scientific Officer, earned $1.2M in 2020, a 20% increase compared to previous year.
Arturo Molina, Chief Medical Officer, received $1.2M in 2020, which increases by 24% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2021.